Ganitumab (AMG 479) is a highly potent monoclonal antibody targeting the type 1 insulin-like growth factor receptor (IGF1R). Recognized for binding IGF1R at low concentrations with a KD value of 0.22 nM, Ganitumab inhibits IGF1R interactions with IGF1 an
CAS Number:
[905703-97-1]
Target:
IGF-1R
* VAT and and shipping costs not included. Errors and price changes excepted